Inventor · disambiguated record
Cheri Snedeker
Also filed as: SNEDEKER CHERI
5 granted patents·2 pending applications·6 citations·filing 2013–2023
70Inventor score
Top patents by PatentIndex Score
7 records- 0190US10953027B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Mar 23, 2021·3 cites·9 claims
- 0274US9284283B2Macrocyclic compounds for modulating IL-17ENSEMBLE THERAPEUTICS CORP·Filed 2013·Granted Mar 15, 2016·3 cites·16 claims
- 0374US2024180941A1Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 0472US12115178B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 0568US11813272B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Nov 14, 2023·0 cites·9 claims
- 0665US11058698B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Jul 13, 2021·0 cites·2 claims
- 0764US2021283157A1Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →